ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )
🇨🇳China
Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Drug: SHR-1316 at a dose 20mg/kg q3wDrug: SHR6390 at a dose of 150mg orally, dailyRadiation: SBRT
- First Posted Date
- 2021-11-24
- Last Posted Date
- 2024-01-03
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT05132790
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Recruiting
- Conditions
- Deterioration, ClinicalPulmonary Embolism and Thrombosis
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05098769
- Locations
- 🇨🇳
Shenjing Hospital of CHINA MEDICAL UNIVERSITY, Shenyang, Liaoning, China
Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer
Phase 2
- Conditions
- HER2-positive Gastric Cancer
- Interventions
- First Posted Date
- 2021-10-07
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 35
- Registration Number
- NCT05070598
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, China
Comparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancersurgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung Cancer
Not Applicable
Completed
- Conditions
- Video-assisted Thoracoscopic SurgeryInflammatory ReactionLife Scores
- First Posted Date
- 2021-10-06
- Last Posted Date
- 2022-08-16
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 68
- Registration Number
- NCT05070026
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
PTNS and PFR in the Treatment of Childhood Constipation
Not Applicable
Completed
- Conditions
- Pelvic Floor DisordersChildhood ALLConstipation
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT05059756
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
Sex Difference Effects on Postoperative Sleep, Inflammation and Cognition in Patients Undergoing General Anesthesia
- Conditions
- Postoperative PainInflammation FunctionPostoperative Cognitive FunctionSex DifferencesPostoperative Sleep Quality
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05059548
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
RCE With FMT in the Treatment of Childhood Constipation
Not Applicable
Completed
- Conditions
- Fecal Microbiota TransplantationConstipation - Functional
- Interventions
- Drug: Fecal supernatantDrug: Placebo
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT05035784
- Locations
- 🇨🇳
Shengjing Hospital, Shenyang, Liaoning, China
Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients
Phase 2
Recruiting
- Conditions
- Breast Neoplasms
- Interventions
- Drug: Next-generation Site-specific human epidermal growth factor receptor 2 (HER2)-targeting Antibody-drug Conjugate (ARX788)
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT04983121
- Locations
- 🇨🇳
Shengjing Hospital affiliated to China Medical University, Shenyang, Liaoning, China
Iron Deficiency Anemia in Twin Pregnancies
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2021-07-23
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04975074
CANA/Met in Non-diabetic Women With PCOS
Phase 1
Completed
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2022-04-21
- Lead Sponsor
- Shengjing Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT04973891
- Locations
- 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China